Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal de Groote

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
European Heart Journal|January 22, 2016
Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseasesYigal M Pinto, Perry M Elliott, Eloisa Arbustini, et al.
Arthritis and Rheumatism|May 30, 2009
The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in FranceEric Hachulla, Pascal de Groote, Virginie Gressin, et al.
The European Respiratory Journal|January 30, 2025
Initial therapy in patients with pulmonary arterial hypertension and cardiovascular comorbiditiesAthénaïs Boucly, David Montani, Fabrice Bauer, et al.
Circulation Research|October 6, 2023
Myocardial Recovery in Recent Onset Dilated Cardiomyopathy: Role of <i>CDCP1</i> and Cardiac FibrosisDuan Liu, Min Wang, Vishakantha Murthy, et al.
American Journal of Respiratory and Critical Care Medicine|May 13, 2022
COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort StudyDavid Montani, Marie-Caroline Certain, Jason Weatherald, et al.
Annals of the Rheumatic Diseases|September 2, 2015
A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naïve systemic sclerosis-associated pulmonary arterial hypertensionSébastien Sanges, David Launay, Rennie L Rhee, et al.
Orphanet Journal of Rare Diseases|July 26, 2021
French recommendations for the management of systemic sclerosisEric Hachulla, Christian Agard, Yannick Allanore, et al.
American Journal of Respiratory and Critical Care Medicine|May 22, 2020
Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1Etienne-Marie Jutant, Xavier Jaïs, Barbara Girerd, et al.
Orphanet Journal of Rare Diseases|April 30, 2023
French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromesMatthieu Groh, Julien Rohmer, Nicolas Etienne, et al.
Journal of the American College of Cardiology|October 6, 2022
Cardiac Outcomes in Adults With Mitochondrial DiseasesKonstantinos Savvatis, Christoffer Rasmus Vissing, Lori Klouvi, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
European Heart Journal|January 22, 2016
Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseasesYigal M Pinto, Perry M Elliott, Eloisa Arbustini, et al.
Arthritis and Rheumatism|May 30, 2009
The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in FranceEric Hachulla, Pascal de Groote, Virginie Gressin, et al.
The European Respiratory Journal|January 30, 2025
Initial therapy in patients with pulmonary arterial hypertension and cardiovascular comorbiditiesAthénaïs Boucly, David Montani, Fabrice Bauer, et al.
Circulation Research|October 6, 2023
Myocardial Recovery in Recent Onset Dilated Cardiomyopathy: Role of <i>CDCP1</i> and Cardiac FibrosisDuan Liu, Min Wang, Vishakantha Murthy, et al.
American Journal of Respiratory and Critical Care Medicine|May 13, 2022
COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort StudyDavid Montani, Marie-Caroline Certain, Jason Weatherald, et al.
Annals of the Rheumatic Diseases|September 2, 2015
A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naïve systemic sclerosis-associated pulmonary arterial hypertensionSébastien Sanges, David Launay, Rennie L Rhee, et al.
Orphanet Journal of Rare Diseases|July 26, 2021
French recommendations for the management of systemic sclerosisEric Hachulla, Christian Agard, Yannick Allanore, et al.
American Journal of Respiratory and Critical Care Medicine|May 22, 2020
Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1Etienne-Marie Jutant, Xavier Jaïs, Barbara Girerd, et al.
Orphanet Journal of Rare Diseases|April 30, 2023
French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromesMatthieu Groh, Julien Rohmer, Nicolas Etienne, et al.
Journal of the American College of Cardiology|October 6, 2022
Cardiac Outcomes in Adults With Mitochondrial DiseasesKonstantinos Savvatis, Christoffer Rasmus Vissing, Lori Klouvi, et al.
Pageof 14